Licensable university IP
Methods of improving microvascular integrity
Methods of improving microvascular integrity is marketed for licensing by Stanford University (OTL). It is documented in US patent US 9,682,071. The current assignee of record is Legacy Pharma Inc Sezc. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2034-03-13. Note: the patent's assignee of record is Legacy Pharma Inc Sezc, not Stanford University (OTL); confirm that Stanford University (OTL) can license it before relying on this listing.
The patent's current assignee of record is Legacy Pharma Inc Sezc, which differs from the marketing institution (Stanford University (OTL)). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 9,682,071 | High | Google Patents |
| Patent title | Methods of improving microvascular integrity | High | Google Patents |
| Current assignee | Legacy Pharma Inc Sezc | Good | Google Patents |
| Original assignee | Intermune Inc | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2014-03-13 | High | Google Patents |
| Priority date | 2013-03-15 | High | Google Patents |
| Publication date | 2017-06-20 | High | Google Patents |
| Expected expiration | 2034-03-13 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 9,682,071 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Original listing
This technology is marketed for licensing by Stanford University (OTL). View the original listing.